Cahill Represents HealthCare Royalty Partners in Financing Transaction for Raptor Pharmaceutical
Date: 07/01/14
Cahill represented Healthcare Royalty Partners in providing $70 million of financing to Raptor Pharmaceutical Corp., an emerging global biopharmaceutical company, including a private placement of $60 million in convertible notes and an additional $10 million of funding under an amended and restated loan agreement, originally entered into in December of 2012. Proceeds will be used to expand manufacturing capacity, to expand commercial operations in Europe and for general corporate purposes.